FDA PUBLIC CALENDAR

Dr. Norris E. Alderson, Associate Commissioner for Science

4/22/04 Rockville, MD

Dr. Lester Crawford

General Public

FDA Science Board Advisory Committee

Murray Lumpkin, M.D., Acting Deputy Commissioner for International and Special Programs

6/10/04 Rockville, MD

Matthew Eckel, Celia Witten, Joyce Frey Vasconcells, Dianne Maloney

European Commission: Paul Weissenberg, Christian Siebert

Human Tissues

Murray Lumpkin, M.D., Acting Deputy Commissioner for International and Special Programs

6/10/04 Rockville, MD

Matthew Eckel, Celia Witten, Joyce Frey Vasconcells, Dianne Maloney

European Commission: Paul Weissenberg, Christian Siebert

Human Tissues

Murray Lumpkin, M.D., Acting Deputy Commissioner for International and Special Programs

6/18/04 Rockville, MD

Melinda Plaisier, Matthew Eckel, Julia Ho, Russell Campbell

Korean Health Sciences Authority: Dr. John Lim, Mrs. Marie Tham

Discuss medical products

Janet Woodcock, M.D.,
Deputy Commissioner  for Operations

6/4/04
Arlington, VA

Linda Kahan
Joanne Less
Steven Turtil
Michael Rogers

Elizabeth Jacobson
Mark Heller, Hale & Dorr LLP

ADVAMED – Submission Workshop

Janet Woodcock, M.D.,
Deputy Commissioner  for Operations

6/6-7/04
San Francisco, CA

James C. Mullen
Senior Executives from BIO

Biotechnology Industry Organization

Janet Woodcock, MD
Deputy Commissioner for Operations

6/14/04
Washington, DC

Carol H. Barstow
Glenn N. Byrd
Kristin Davis

Eleanor M. Perfetto
Brenton E. James
Arthur L. Caplan

Drug Information Association

Peter Pitts, Associate Commissioner for External Relations

6/7-9/04 San Francisco, CA

Nancy Myers

BIO Conference Attendees

Future direction of FDA

Peter Pitts, Associate Commissioner for External Relations

6/10/04 New York, NY

Ellen Shapiro

Members of the National Consumer League, NY

Safe use of OTC

Peter Pitts, Associate Commissioner for External Relations

6/14/04 Philadelphia, PA

None

Rhona Applebaum, Coca-Cola Corporation

Nutrition Facts Panel

Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research

6/1/04 Bethesda, MD

CBER Senior Management: Mark Weinstein (OBRR); and other FDA staff, including Dr. Janet Woodcock and Dr. Theresa Mullin

Plasma Protein Therapeutics Association (PPTA)

Discuss concerns about possible generics for plasma therapeutics industry.

Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research

6/2/04 Bethesda, MD

CBER Senior Management

Am. Assn. of Blood Banks, America's Blood Centers, Am. Red Cross, Dept. of Defense, other DHHS including CDC

Bacterial Contamination Task Force: Roundtable discussion including FDA licensing issues, including clearance of bacterial detection devices, prestorage pooling and extension of platelet storage.

Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research

6/4/04 Bethesda, MD

CBER Senior Management

AdvaMed 14th Annual Device Submissions Workshop

"CBER: Devices, Technology and Public Health --Looking Ahead"

Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research

6/8-9/04 San Francisco, CA

CBER Senior Management along with CDRH and CDER staff

Biologics Industry Organization (BIO) 2004 Annual International Convention

Global Regulatory Environment Town Hall session "CBER 2004 Update: Innovation Advancing Public Health"

Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research

6/8-9/04 Bethesda, MD

CBER Senior Management and other FDA Staff

Open to Public

Workshop on Strategies for Developing Therapeutics that directly Target Anthrax and its Toxins. Dr. Goodman opened the meeting and welcomed speakers.

Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research

6/16-17/04 Bethesda, MD

Other CBER Staff

IOM Workshop "Pandemic Influenza: Assessing Capabilities for Prevention and Response"

Status of government planning

Daniel E. Troy
Chief Counsel

6/4/04 Minneapolis, MN

Members of CLE Health Law Institute

Made presentation